Combined therapy of prednisone and mTOR inhibitor sirolimus for treating retroperitoneal fibrosis.

Authors:
Gao H; Liu S; Mai Y; Wang Y; Zhang X and 3 more

Journal:
Ann Rheum Dis

Publication Year: 2023

DOI:
10.1136/ard-2022-223736

PMCID:
PMC10176363

PMID:
36720581

Journal Information

Full Title: Ann Rheum Dis

Abbreviation: Ann Rheum Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Rheumatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests: None declared."

Evidence found in paper:

"Funding: This study was supported by the Greater Bay Area Research Institute of Precision Medicine (Guangzhou) Research Grant (I0005), National Natural Science Foundation of China (81771678) and Peking University International Hospital Research Grant (YN2019QN02)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025